메뉴 건너뛰기
Practitioner
Volumn 241, Issue 1571, 1997, Pages 74-79
Managing PLE and actinic prurigo

(2)  Grabczyska, S A a   Hawk, J L M a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; THALIDOMIDE;
EID: 0345877670     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (9)
References (6)
  • 1
    • 0028214129 scopus 로고
    • Polymorphic light eruption: Prevalence in Australia and England
    • Pao C, et al. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol 1994; 150:62-64
    • (1994) Br J Dermatol , vol.150 , pp. 62-64
    • Pao, C.1
  • 2
    • 0029965238 scopus 로고    scopus 로고
    • HLA-DR4 may determine expression of actinic prurigo in British patients
    • Menage H du P, et al. HLA-DR4 may determine expression of actinic prurigo in British patients. J Invest Dermatol 1996; 106(2): 362-367
    • (1996) J Invest Dermatol , vol.106 , Issue.2 , pp. 362-367
    • Menage, H.D.P.1
  • 4
    • 0023135003 scopus 로고
    • Prophylactic PUVA and UVB therapy in polymorphic light eruption - A controlled trial
    • Murphy GM, et al. Prophylactic PUVA and UVB therapy in polymorphic light eruption - a controlled trial. Br J Dermatol 1987; 116:531-538
    • (1987) Br J Dermatol , vol.116 , pp. 531-538
    • Murphy, G.M.1
  • 5
    • 0026631620 scopus 로고
    • Cutaneous and ocular ramifications of ultraviolet radiation
    • Lennan S, Van Voorhees A. Cutaneous and ocular ramifications of ultraviolet radiation. Dermatology Clinics 1992; 10(3):483-504
    • (1992) Dermatology Clinics , vol.10 , Issue.3 , pp. 483-504
    • Lennan, S.1    Van Voorhees, A.2
  • 6
    • 0020537723 scopus 로고
    • Thalidomide in actinic prurigo
    • Lovell CR, et al. Thalidomide in actinic prurigo. Br J Dermatol 1983; 108:467-171
    • (1983) Br J Dermatol , vol.108 , pp. 467-1171
    • Lovell, C.R.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.